Bovine herpesvirus 1 infection and infectious bovine rhinotracheitis

Veterinary Research

Volumn 38, Issue 2, 2007, Pages 181-209

  Muylkens, Benoît ^a   Thiry, Julien ^a   Kirten, Philippe ^a   Schynts, Frédéric ^b   Thiry, Etienne ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CER   (Belgium)

Author keywords

Alphaherpesvirus; Bovine; Infectious; Latency; Marker; Rhinotracheitis; Vaccine

Indexed keywords

HERPES VACCINE; INACTIVATED VACCINE;

BRAIN INFECTION; CATTLE DISEASE; DISEASE TRANSMISSION; IMMUNE RESPONSE; IMMUNITY; INFECTION CONTROL; INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS; NONHUMAN; PATHOGENESIS; REVIEW; SYMPTOMATOLOGY; VACCINATION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; CATTLE; HERPESVIRUS 1, BOVINE; INFECTIOUS BOVINE RHINOTRACHEITIS;

ANIMALIA; BOS; BOVINAE; BOVINE HERPESVIRUS 1;

EID: 34147183179     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1051/vetres:2006059     Document Type: Review

References (227)

1. Abril C., Engels M., Liman A., Hilbe M., Albini S., Franchini M., Suter M., Ackermann M., Both viral and host factors contribute to neurovirulence of bovine herpesviruses 1 and 5 in interferon receptor-deficient mice, J. Virol. (2004) 78:3644-3653.
2. Ackermann M., Engels M., Pro and contra IBR-eradication, Vet. Microbiol. (2006) 113:293-302.
3. Allen G.P., Breathnach C.C., Quantification by real-time PCR of the magnitude and duration of leucocyte-associated viraemia in horses infected with neuropathogenic vs. non-neuropathogenic strains of EHV-1, Equine Vet. J. (2006) 38:252-257.
4. Antinone S.E., Shubeita G.T., Coller K.E., Lee J.I., Haverlock-Moyns S., Gross S.P., Smith G.A., The Herpesvirus capsid surface protein, VP26, and the majority of the tegument proteins are dispensable for capsid transport toward the nucleus, J. Virol. (2006) 80:5494-5498.
5. Babiuk L.A., van Drunen Littel-van den Hurk S., Tikoo S.K., Immunology of bovine herpesvirus 1 infection, Vet. Microbiol. (1996) 53:31-42.
6. Baranowski E., Keil G., Lyaku J., Rijsewijk F.A., van Oirschot J.T., Pastoret P.P., Thiry E., Structural and functional analysis of bovine herpesvirus 1 minor glycoproteins, Vet. Microbiol. (1996) 53:91-101.
7. Bataille D., Epstein A., Herpes simplex virus replicative concatemers contain L components in inverted orientation, Virology (1994) 203:384-388.
8. Bataille D., Epstein A.L., Equimolar generation of the four possible arrangements of adjacent L components in herpes simplex virus type 1 replicative intermediates, J. Virol. (1997) 71:7736-7743.
9. Beer M., Konig P., Schielke G., Trapp S., Diagnostic markers in the prevention of bovine herpesvirus type 1: possibilities and limitations, Berl. Munch. Tierarztl. Wochenschr. (2003) 116:183-191.
10. Boelaert F., Speybroeck N., de Kruif A., Aerts M., Burzykowski T., Molenberghs G., Berkvens D.L., Risk factors for bovine herpesvirus-1 seropositivity, Prev. Vet. Med. (2005) 69:285-295.
11. Bosch J.C., Kaashoek M.J., Kroese A.H., van Oirschot J.T., An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines, Vet. Microbiol. (1996) 52:223-234.
12. Bosch J.C., Kaashoek M.J., van Oirschot J.T., Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine, Vaccine (1997) 15:1512-1517.
13. Bosch J.C., De Jong M.C.M., Franken P., Frankena K., Hage J.J., Kaashoek M.J., Maris-Veldhuis M.A., Noordhuizen J.P.T.M., Van der Poel W.H.M., Verhoeff J., Weerdmeester K., Zimmer G.M., Van Oirschot J.T., An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the field, Vaccine (1998) 16:265-271.
14. Bowland S.L., Shewen P.E., Bovine respiratory disease: commercial vaccines currently available in Canada, Can. Vet. J. (2000) 41:33-48.
15. Bradshaw B.J., Edwards S., Antibody isotype responses to experimental infection with bovine herpesvirus 1 in calves with colostrally derived antibody, Vet. Microbiol. (1996) 53:143-151.
16. Bratanich A.C., Jones C.J., Localization of cis-acting sequences in the latency-related promoter of bovine herpesvirus 1 which are regulated by neuronal cell type factors and immediate-early genes, J. Virol. (1992) 66:6099-6106.
17. Brown T.T. Jr., Ananaba G., Effect of respiratory infections caused by bovine herpesvirus-1 or parainfluenza-3 virus on bovine alveolar macrophage functions, Am. J. Vet. Res. (1988) 49:1447-1451.
18. Bryan L.A., Fenton R.A., Misra V., Haines D.M., Fatal, generalized bovine herpesvirus type-1 infection associated with a modified-live infectious bovine rhinotracheitis parainfluenza-3 vaccine administered to neonatal calves, Can. Vet. J. (1994) 35:223-228.
19. Bryant N.A., Davis-Poynter N., Vanderplasschen A., Alcami A., Glycoprotein G isoforms from some alphaherpesviruses k, EMBO J. (2003) 22:833-846.
20. Burgos J.S., Ramirez C., Sastre I., Bullido M.J., Valdivieso F., ApoE4 is more efficient than E3 in brain access by herpes simplex virus type 1, Neuroreport. (2003) 14:1825-1827.
21. Burgos J.S., Ramirez C., Sastre I., Valdivieso F., Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA, J. Virol. (2006) 80:5383-5387.
22. Campadelli-Fiume G., Cocchi F., Menotti L., Lopez M., The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells, Rev. Med. Virol. (2000) 10:305-319.
23. Campos M., Rossi C.R., Cytotoxicity of bovine lymphocytes after treatment with lymphokines, Am. J. Vet. Res. (1986) 47:1524-1528.
24. Campos M., Ohmann H.B., Hutchings D., Rapin N., Babiuk L.A., Lawman M.J., Role of interferon-gamma in inducing cytotoxicity of peripheral blood mononuclear leukocytes to bovine herpesvirus type 1 (BHV-1)-infected cells, Cell. Immunol. (1989) 120:259-269.
25. Carpenter D.E., Misra V., The most abundant protein in bovine herpes 1 virions is a homologue of herpes simplex virus type 1 UL47, J. Gen. Virol. (1991) 72:3077-3084.
26. Casrouge A., Zhang S.Y., Eidenschenk C., Jouanguy E., Puel A., Yang K., Alcais A., Picard C., Mahfoufi N., Nicolas N., Lorenzo L., Plancoulaine S., Senechal B., Geissmann F., Tabeta K., Hoebe K., Du X., Miller R.L., Heron B., Mignot C., de Villemeur T.B., Lebon P., Dulac O., Rozenberg F., Beutler B., Tardieu M., Abel L., Casanova J.L., Herpes simplex virus encephalitis in human UNC-93B deficiency, Science (2006) 314:308-312.
27. Castrucci G., Ferrari M., Traldi V., Tartaglione E., Effects in calves of mixed infections with bovine viral diarrhea virus and several other bovine viruses, Comp. Immunol. Microbiol. Infect. Dis. (1992) 15:261-270.
28. Chapgier A., Wynn R.F., Jouanguy E., Filipe-Santos O., Zhang S., Feinberg J., Hawkins K., Casanova J.L., Arkwright P.D., Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo, J. Immunol. (2006) 176:5078-5083.
29. Chew D.S., Choi K.P., Leung M.Y., Scoring schemes of palindrome clusters for more sensitive prediction of replication origins in herpesviruses, Nucleic Acids Res. (2005) 33:e134.
30. Chow T.L., Molello J.A., Owen N.V., Abortion experimentally induced in cattle by infectious bovine rhinotracheitis virus, J. Am. Vet. Med. Assoc. (1964) 144:1005-1007.
31. Ciacci-Zanella J., Stone M., Henderson G., Jones C., The latency-related gene of bovine herpesvirus 1 inhibits programmed cell death, J. Virol. (1999) 73:9734-9740.
32. Costes B., Ruiz-Arguello M.B., Bryant N.A., Alcami A., Vanderplasschen A., Both soluble and membrane-anchored forms of Felid herpesvirus 1 glycoprotein G function as a broad-spectrum chemokine-binding protein, J. Gen. Virol. (2005) 86:3209-3214.
33. Delhon G., Moraes M.P., Lu Z., Afonso C.L., Flores E.F., Weiblen R., Kutish G.F., Rock D.L., Genome of bovine herpesvirus 5, J. Virol. (2003) 77:10339-10347.
34. Denis M., Splitter G., Pastoret P.-P., Babiuk L.A., Infectious bovine rhinotracheitis (bovine herpesvirus 1): helper T cells, cytotoxic T cells and NK cells, CRC Press, Boca Raton, 1994.
35. Devireddy L.R., Jones C.J., Activation of caspases and p53 by bovine herpesvirus 1 infection results in programmed cell death and efficient virus release, J. Virol. (1999) 73:3778-3788.
36. Dingwell K.S., Brunetti C.R., Hendricks R.L., Tang Q., Tang M., Rainbow A.J., Johnson D.C., Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells, J. Virol. (1994) 68:834-845.
37. Dingwell K.S., Doering L.C., Johnson D.C., Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus, J. Virol. (1995) 69:7087-7098.
38. Dispas M., Schynts F., Lemaire M., Letellier C., Vanopdenbosch E., Thiry E., Kerkhofs P., Isolation of a glycoprotein Edeleted bovine herpesvirus type 1 strain in the field, Vet. Rec. (2003) 153:209-212.
39. Dispas M., Lemaire M., Speybroeck N., Berkvens D., Dupont A., Boelart F., Dramaix M., Vanopdenbosch E., Kerkhofs P., Thiry E., Deux protocoles d'hyperimmunisation au moyen de vaccins marqués réduisent l'incidence de séroconversion envers l'herpèsvirus bovin 1 en cheptels laitiers : résultats d'une étude sur le terrain, Ann. Med. Vet. (2004) 148:47-61.
40. D'Offay J.M., Mock R.E., Fulton R.W., Isolation and characterization of encephalitic bovine herpesvirus type 1 isolates from cattle in North America, Am. J. Vet. Res. (1993) 54:534-539.
41. Dohner K., Wolfstein A., Prank U., Echeverri C., Dujardin D., Vallee R., Sodeik B., Function of dynein and dynactin in herpes simplex virus capsid transport, Mol. Biol. Cell (2002) 13:2795-2809.
42. Dupuis S., Jouanguy E., Al-Hajjar S., Fieschi C., Al-Mohsen I.Z., Al-Jumaah S., Yang K., Chapgier A., Eidenschenk C., Eid P., Al Ghonaium A., Tufenkeji H., Frayha H., Al-Gazlan S., Al-Rayes H., Schreiber R.D., Gresser I., Casanova J.L., Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency, Nat. Genet. (2003) 33:388-391.
43. Edwards S., White H., Nixon P., A study of the predominant genotypes of bovid herpesvirus 1 found in the UK, Vet. Microbiol. (1990) 22:213-223.
44. Edwards S., Newman R.H., White H., The virulence of British isolates of bovid herpesvirus 1 in relationship to viral genotype, Br. Vet. J. (1991) 147:216-231.
45. Engels M., Steck F., Wyler R., Comparison of the genomes of infectious bovine rhinotracheitis and infectious pustular vulvovaginitis virus strains by restriction endonuclease analysis, Arch. Virol. (1981) 67:169-174.
46. Engels M., Ackermann M., Pathogenesis of ruminant herpesvirus infections, Vet. Microbiol. (1996) 53:3-15.
47. Enquist L.W., Husak P.J., Banfield B.W., Smith G.A., Infection and spread of alphaherpesviruses in the nervous system, Adv. Virus Res. (1998) 51:237-347.
48. Esclatine A., Taddeo B., Evans L., Roizman B., The herpes simplex virus 1 UL41 gene-dependent destabilization of cellular RNAs is selective and may be sequence-specific, Proc. Natl. Acad. Sci. USA (2004) 101:3603-3608.
49. Fenwick M.L., Walker M.J., Suppression of the synthesis of cellular macromolecules by herpes simplex virus, J. Gen. Virol. (1978) 41:37-51.
50. Fraefel C., Wirth U.V., Vogt B., Schwyzer M., Immediate-early transcription over covalently joined genome ends of bovine herpesvirus 1: the circ gene, J. Virol. (1993) 67:1328-1333.
51. Fraefel C., Ackermann M., Schwyzer M., Identification of the bovine herpesvirus 1 circ protein, a myristylated and virion-associated polypeptide which is not essential for virus replication in cell culture, J. Virol. (1994) 68:8082-8088.
52. Fuchs M., Hubert P., Detterer J., Rziha H.J., Detection of bovine herpesvirus type 1 in blood from naturally infected cattle by using a sensitive PCR that discriminates between wild-type virus and virus lacking glycoprotein E, J. Clin. Microbiol. (1999) 37:2498-2507.
53. Garber D.A., Beverley S.M., Coen D.M., Demonstration of circularization of herpes simplex virus DNA following infection using pulsed field gel electrophoresis, Virology (1993) 197:459-462.
54. Geiser V., Inman M., Zhang Y., Jones C., The latency-related gene of bovine herpesvirus-1 can inhibit the ability of bICP0 to activate productive infection, J. Gen. Virol. (2002) 83:2965-2971.
55. Geiser V., Zhang Y., Jones C., Analysis of a bovine herpesvirus 1 recombinant virus that does not express the bICP0 protein, J. Gen. Virol. (2005) 86:1987-1996.
56. Geraghty R.J., Krummenacher C., Cohen G.H., Eisenberg R.J., Spear P.G., Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor, Science (1998) 280:1618-1620.
57. Gerber S.I., Belval B.J., Herold B.C., Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism, Virology (1995) 214:29-39.
58. Gerdts V., Beyer J., Lomniczi B., Mettenleiter T.C., Pseudorabies virus expressing bovine herpesvirus 1 glycoprotein B exhibits altered neurotropism and increased neurovirulence, J. Virol. (2000) 74:817-827.
59. Gibbs E.P., Rweyemamu M.M., Bovine herpesviruses. Part I. Bovine herpesvirus 1, Vet. Bull. (1977) 47:317-343.
60. Gogev S., Vanderheijden N., Lemaire M., Schynts F., D'Offay J., Deprez I., Adam M., Eloit M., Thiry E., Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD, Vaccine (2002) 20:1451-1465.
61. Gogev S., de Fays K., Versali M.F., Gautier S., Thiry E., Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1, Vaccine (2004) 22:1946-1953.
62. Gogev S., Georgin J.P., Schynts F., Vanderplasschen A., Thiry E., Bovine herpesvirus 1 glycoprotein D expression in bovine upper respiratory tract mediated by a human adenovirus type 5, Vet. Res. (2004) 35:715-721.
63. Granzow H., Klupp B.G., Fuchs W., Veits J., Osterrieder N., Mettenleiter T.C., Egress of alphaherpesviruses: comparative ultrastructural study, J. Virol. (2001) 75:3675-3684.
64. Gupta P.K., Saini M., Gupta L.K., Rao V.D., Bandyopadhyay S.K., Butchaiah G., Garg G.K., Garg S.K., Induction of immune responses in cattle with a DNA vaccine encoding glycoprotein C of bovine herpesvirus-1, Vet. Microbiol. (2001) 78:293-305.
65. Hage J.J., Schukken Y.H., Barkema H.W., Benedictus G., Rijsewijk F.A., Wentink G.H., Population dynamics of bovine herpesvirus 1 infection in a dairy herd, Vet. Microbiol. (1996) 53:169-180.
66. Hage J.J., Vellema P., Schukken Y.H., Barkema H.W., Rijsewijk F.A., van Oirschot J.T., Wentink G.H., Sheep do not have a major role in bovine herpesvirus 1 transmission, Vet. Microbiol. (1997) 57:41-54.
67. Hage J.J., Schukken Y.H., Dijkstra T., Barkema H.W., van Valkengoed P.H., Wentink G.H., Milk production and reproduction during a subclinical bovine herpesvirus 1 infection on a dairy farm, Prev. Vet. Med. (1998) 34:97-106.
68. Hanon E., Vanderplasschen A., Lyaku S., Keil G., Denis M., Pastoret P.P., Inactivated bovine herpesvirus 1 induces apoptotic cell death of mitogen-stimulated bovine peripheral blood mononuclear cells, J. Virol. (1996) 70:4116-4120.
69. Hanon E., Meyer G., Vanderplasschen A., Dessy-Doize C., Thiry E., Pastoret P.P., Attachment but not penetration of bovine herpesvirus 1 is necessary to induce apoptosis in target cells, J. Virol. (1998) 72:7638-7641.
70. Hanon E., Keil G., van Drunen Littel-van den Hurk S., Griebel P., Vanderplasschen A., Rijsewijk F.A., Babiuk L., Pastoret P.P., Bovine herpesvirus 1-induced apoptotic cell death: role of glycoprotein D, Virology (1999) 257:191-197.
71. Henderson G., Perng G.C., Nesburn A.B., Wechsler S.L., Jones C., The latency-related gene encoded by bovine herpesvirus 1 can suppress caspase 3 and caspase 9 cleavage during productive infection, J. Neurovirol. (2004) 10:64-70.
72. Henderson G., Zhang Y., Inman M., Jones D., Jones C., Infected cell protein 0 encoded by bovine herpesvirus 1 can activate caspase 3 when overexpressed in transfected cells, J. Gen. Virol. (2004) 85:3511-3516.
73. Henderson G., Zhang Y., Jones C., The Bovine herpesvirus 1 gene encoding infected cell protein 0 (bICP0) can inhibit interferon-dependent transcription in the absence of other viral genes, J. Gen. Virol. (2005) 86:2697-2702.
74. Herold B.C., Gerber S.I., Belval B.J., Siston A.M., Shulman N., Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry, J. Virol. (1996) 70:3461-3469.
75. Higgins R.J., Edwards S., Systemic neonatal infectious bovine rhinotracheitis virus infection in suckler calves, Vet. Rec. (1986) 119:177-178.
76. Hinkley S., Ambagala A.P., Jones C.J., Srikumaran S., A vhs-like activity of bovine herpesvirus-1, Arch. Virol. (2000) 145:2027-2046.
77. Horiuchi M., Yamazaki N., Furuoka H., Matsui T., Nakagawa M., Ishiguro N., Shinagawa M., Restriction endonuclease analysis of bovine herpesvirus type 1 isolates from calves with fatal encephalitis: comparison with vaccine virus, J. Vet. Med. Sci. (1995) 57:577-580.
78. Hossain A., Schang L.M., Jones C., Identification of gene products encoded by the latency-related gene of bovine herpesvirus 1, J. Virol. (1995) 69:5345-5352.
79. Huemer H.P., Larcher C., van Drunen Littel-van den Hurk S., Babiuk L.A., Species selective interaction of Alphaherpesvirinae with the "unspecific" immune system of the host, Arch. Virol. (1993) 130:353-364.
80. Inman M., Lovato L., Doster A., Jones C., A mutation in the latency-related gene of bovine herpesvirus 1 leads to impaired ocular shedding in acutely infected calves, J. Virol. (2001) 75:8507-8515.
81. Inman M., Lovato L., Doster A., Jones C., A mutation in the latency-related gene of bovine herpesvirus 1 disrupts the latency reactivation cycle in calves, J. Virol. (2002) 76:6771-6779.
82. Inman M., Zhou J., Webb H., Jones C., Identification of a novel bovine herpesvirus 1 transcript containing a small open reading frame that is expressed in trigeminal ganglia of latently infected cattle, J. Virol. (2004) 78:5438-5447.
83. Ioannou X.P., Griebel P., Hecker R., Babiuk L.A., van Drunen Littel-van den Hurk S., The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides, J. Virol. (2002) 76:9002-9010.
84. Jacob R.J., Morse L.S., Roizman B., Anatomy of herpes simplex virus DNA. XII. Accumulation of head-to-tail concatemers in nuclei of infected cells and their role in the generation of the four isomeric arrangements of viral DNA, J. Virol. (1979) 29:448-457.
85. Jean J.H., Ben-Porat T., Appearance in vivo of single-stranded complementary ends on parental herpesvirus DNA, Proc. Natl. Acad. Sci. USA (1976) 73:2674-2678.
86. Jiang Y., Hossain A., Winkler M.T., Holt T., Doster A., Jones C., A protein encoded by the latency-related gene of bovine herpesvirus 1 is expressed in trigeminal ganglionic neurons of latently infected cattle and interacts with cyclin-dependent kinase 2 during productive infection, J. Virol. (1998) 72:8133-8142.
87. Jones C., Geiser V., Henderson G., Jiang Y., Meyer F., Perez S., Zhang Y., Functional analysis of bovine herpesvirus 1 (BHV-1) genes expressed during latency, Vet. Microbiol. (2006) 113:199-210.
88. Kaashoek M.J., Straver P.H., Van R.E., Quak J., van Oirschot J.T., Virulence, immunogenicity and reactivation of seven bovine herpesvirus 1.1 strains: clinical and virological aspects, Vet. Rec. (1996) 139:416-421.
89. Kaashoek M.J., Rijsewijk F.A., Ruuls R.C., Keil G.M., Thiry E., Pastoret P.P., van Oirschot J.T., Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene, Vaccine (1998) 16:802-809.
90. Kerkhofs P., Renjifo X., Toussaint J.F., Letellier C., Vanopdenbosch E., Wellemans G., Enhancement of the immune response and virological protection of calves against bovine herpesvirus type 1 with an inactivated gE-deleted vaccine, Vet. Rec. (2003) 152:681-686.
91. Khattar S.K., van Drunen Littel-van den Hurk S., Babiuk L.A., Tikoo S.K., Identification and transcriptional analysis of a 3′-coterminal gene cluster containing UL1, UL2, UL3, and UL3.5 open reading frames of bovine herpesvirus-1, Virology (1995) 213:28-37.
92. Kinchington P.R., Reinhold W.C., Casey T.A., Straus S.E., Hay J., Ruyechan W.T., Inversion and circularization of the varicella-zoster virus genome, J. Virol. (1985) 56:194-200.
93. Klupp B.G., Granzow H., Mettenleiter T.C., Effect of the pseudorabies virus US3 protein on nuclear membrane localization of the UL34 protein and virus egress from the nucleus, J. Gen. Virol. (2001) 82:2363-2371.
94. Koppel R., Fraefel C., Vogt B., Bello L.J., Lawrence W.C., Schwyzer M., Recombinant bovine herpesvirus-1 (BHV-1) lacking transactivator protein BICPO entails lack of glycoprotein C and severely reduced infectivity, Biol. Chem. (1996) 377:787-795.
95. Koppers-Lalic D., Rijsewijk F.A., Verschuren S.B., van Gaans-Van den Brink J.A., Neisig A., Ressing M.E., Neefjes J., Wiertz E.J., The UL41-encoded virion host shutoff (vhs) protein and vhs-independent mechanisms are responsible for down-regulation of MHC class I molecules by bovine herpesvirus 1, J. Gen. Virol. (2001) 82:2071-2081.
96. Koppers-Lalic D., Reits E.A., Ressing M.E., Lipinska A.D., Abele R., Koch J., Marcondes Rezende M., Admiraal P., van Leeuwen D., Bienkowska-Szewczyk K., Mettenleiter T.C., Rijsewijk F.A., Tampe R., Neefjes J., Wiertz E.J., Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing, Proc. Natl. Acad. Sci. USA (2005) 102:5144-5149.
97. Kramps J.A., Banks M., Beer M., Kerkhofs P., Perrin M., Wellenberg G.J., van Oirschot J.T., Evaluation of tests for antibodies against bovine herpesvirus 1 performed in national reference laboratories in Europe, Vet. Microbiol. (2004) 102:169-181.
98. Kupferschmied H.U., Kihm U., Bachmann P., Müller K.H., Ackermann M., Transmission of IBR/IPV virus in bovine semen: A case report, Theriogenology (1986) 25:439-443.
99. Kwong A.D., Frenkel N., Herpes simplex virus-infected cells contain a function(s) that destabilizes both host and viral mRNAs, Proc. Natl. Acad. Sci. USA (1987) 84:1926-1930.
100. Lehmann D., Sodoyer R., Leterme S., Crevat D., Improvement of serological discrimination between herpesvirus-infected animals and animals vaccinated with marker vaccines, Vet. Microbiol. (2002) 86:59-68.
101. Leite F., Sylte M.J., O'Brien S., Schultz R., Peek S., van Reeth K., Czuprynski C.J., Effect of experimental infection of cattle with bovine herpesvirus-1 (BHV-1) on the ex vivo interaction of bovine leukocytes with Mannheimia (Pasteurella) haemolytica leukotoxin, Vet. Immunol. Immunopathol. (2002) 84:97-110.
102. Leite F., Kuckleburg C., Atapattu D., Schultz R., Czuprynski C.J., BHV-1 infection and inflammatory cytokines amplify the interaction of Mannheimia haemolytica leukotoxin with bovine peripheral blood mononuclear cells in vitro, Vet. Immunol. Immunopathol. (2004) 99:193-202.
103. Leite F., Atapattu D., Kuckleburg C., Schultz R., Czuprynski C.J., Incubation of bovine PMNs with conditioned medium from BHV-1 infected peripheral blood mononuclear cells increases their susceptibility to Mannheimia haemolytica leukotoxin, Vet. Immunol. Immunopathol. (2005) 103:187-193.
104. Lemaire M., Meyer G., Baranowski E., Schynts F., Wellemans G., Kerkhofs P., Thiry E., Production of bovine herpesvirus type 1-seronegative latent carriers by administration of a live-attenuated vaccine in passively immunized calves, J. Clin. Microbiol. (2000) 38:4233-4238.
105. Lemaire M., Weynants V., Godfroid J., Schynts F., Meyer G., Letesson J.J., Thiry E., Effects of bovine herpesvirus type 1 infection in calves with maternal antibodies on immune response and virus latency, J. Clin. Microbiol. (2000) 38:1885-1894.
106. Lemaire M., Schynts F., Meyer G., Georgin J.P., Baranowski E., Gabriel A., Ros C., Belak S., Thiry E., Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies, Vaccine (2001) 19:4795-4804.
107. Leung-Tack P., Audonnet J.C., Riviere M., The complete DNA sequence and the genetic organization of the short unique region (US) of the bovine herpesvirus type 1 (ST strain), Virology (1994) 199:409-421.
108. Leuzinger H., Ziegler U., Schraner E.M., Fraefel C., Glauser D.L., Heid I., Ackermann M., Mueller M., Wild P., Herpes simplex virus 1 envelopment follows two diverse pathways, J. Virol. (2005) 79:13047-13059.
109. Li Y., van Drunen Littel-van den Hurk S., Babiuk L.A., Liang X., Characterization of cell-binding properties of bovine herpesvirus 1 glycoproteins B, C, and D: identification of a dual cell-binding function of gB, J. Virol. (1995) 69:4758-4768.
110. Liang X., Babiuk L.A., Zamb T.J., An in vivo study of a glycoprotein gIII-negative bovine herpesvirus 1 (BHV-1) mutant expressing beta-galactosidase: evaluation of the role of gIII in virus infectivity and its use as a vector for mucosal immunization, Virology (1992) 189:629-639.
111. Liang X., Pyne C., Li Y., Babiuk L.A., Kowalski J., Delineation of the essential function of bovine herpesvirus 1 gD: an indication for the modulatory role of gD in virus entry, Virology (1995) 207:429-441.
112. Liang X., Chow B., Babiuk L.A., Study of immunogenicity and virulence of bovine herpesvirus 1 mutants deficient in the UL49 homolog, UL49.5 homolog and dUTPase genes in cattle, Vaccine (1997) 15:1057-1064.
113. Liang X.P., Babiuk L.A., van Drunen Littelvan den Hurk S., Fitzpatrick D.R., Zamb T.J., Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV, J. Virol. (1991) 65:1124-1132.
114. Ligas M.W., Johnson D.C., A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells, J. Virol. (1988) 62:1486-1494.
115. Lipinska A.D., Koppers-Lalic D., Rychlowski M., Admiraal P., Rijsewijk F.A., Bienkowska-Szewczyk K., Wiertz E.J., Bovine herpesvirus 1 UL49.5 protein inhibits the transporter associated with antigen processing despite complex formation with glycoprotein M, J. Virol. (2006) 80:5822-5832.
116. Liu T., Khanna K.M., Chen X., Fink D.J., Hendricks R.L., CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons, J. Exp. Med. (2000) 191:1459-1466.
117. Loehr B.I., Willson P., Babiuk L.A., van Drunen Littel-van den Hurk S., Gene gunmediated DNA immunization primes development of mucosal immunity against bovine herpesvirus 1 in cattle, J. Virol. (2000) 74:6077-6086.
118. Lovato L., Inman M., Henderson G., Doster A., Jones C., Infection of cattle with a bovine herpesvirus 1 strain that contains a mutation in the latency-related gene leads to increased apoptosis in trigeminal ganglia during the transition from acute infection to latency, J. Virol. (2003) 77:4848-4857.
119. Mallory S., Sommer M., Arvin A.M., Analysis of the glycoproteins I and E of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids, J. Infect. Dis. (1998) 178:S22-26.
120. Mars M.H., de Jong M.C., van Maanen C., Hage J.J., van Oirschot J.T., Airborne transmission of bovine herpesvirus 1 infections in calves under field conditions, Vet. Microbiol. (2000) 76:1-13.
121. Mars M.H., de Jong M.C., van Oirschot J.T., A gE-negative BHV1 vaccine virus strain cannot perpetuate in cattle populations, Vaccine (2000) 18:2120-2124.
122. Mars M.H., de Jong M., Franken P., van Oirschot J.T., Efficacy of a live glycoprotein E-negative bovine herpesvirus 1 vaccine in cattle in the field, Vaccine (2001) 19:1924-1930.
123. Mechor G.D., Rousseaux C.G., Radostits O.M., Babiuk L.A., Petrie L., Protection of newborn calves against fatal multisystemic infectious bovine rhinotracheitis by feeding colostrum from vaccinated cows, Can. J. Vet. Res. (1987) 51:452-459.
124. Mettenleiter T.C., Herpesvirus assembly and egress, J. Virol. (2002) 76:1537-1547.
125. Mettenleiter T.C., Intriguing interplay between viral proteins during herpesvirus assembly or: the herpesvirus assembly puzzle, Vet. Microbiol. (2006) 113:163-169.
126. Mettenleiter T.C., Klupp B.G., Granzow H., Herpesvirus assembly: a tale of two membranes, Curr. Opin. Microbiol. (2006) 9:423-429.
127. Mettenleiter T.C., Minson T., Egress of alphaherpesviruses, J. Virol. (2006) 80:1610-1611; author reply 1611-1612.
128. Metzler A.E., Matile H., Gassmann U., Engels M., Wyler R., European isolates of bovine herpesvirus 1: a comparison of restriction endonuclease sites, polypeptides, and reactivity with monoclonal antibodies, Arch. Virol. (1985) 85:57-69.
129. Meyer G., Lemaire M., Lyaku J., Pastoret P.P., Thiry E., Establishment of a rabbit model for bovine herpesvirus type 5 neurological acute infection, Vet. Microbiol. (1996) 51:27-40.
130. Meyer G., Vlcek C., Paces V., O'Hara M.K., Pastoret P.P., Thiry E., Schwyzer M., Sequence analysis of the bovine herpesvirus type 1 genes homologous to the DNA polymerase (UL30), the major DNA-binding protein (UL29) and ICP18.5 assembly protein (UL28) genes of herpes simplex virus, Arch. Virol. (1997) 142:89-102.
131. Meyer G., Hanon E., Georlette D., Pastoret P.P., Thiry E., Bovine herpesvirus type 1 glycoprotein H is essential for penetration and propagation in cell culture, J. Gen. Virol. (1998) 79:1983-1987.
132. Meyer G., Lemaire M., Ros C., Belak K., Gabriel A., Cassart D., Coignoul F., Belak S., Thiry E., Comparative pathogenesis of acute and latent infections of calves with bovine herpesvirus types 1 and 5, Arch. Virol. (2001) 146:633-652.
133. Mikloska Z., Cunningham A.L., Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission, J. Virol. (2001) 75:11821-11826.
134. Miller J.M., Van der Maaten M.J., Reproductive tract lesions in heifers after intrauterine inoculation with infectious bovine rhinotracheitis virus, Am. J. Vet. Res. (1984) 45:790-794.
135. Miller J.M., Van der Maaten M.J., Experimentally induced infectious bovine rhinotracheitis virus infection during early pregnancy: effect on the bovine corpus luteum and conceptus, Am. J. Vet. Res. (1986) 47:223-228.
136. Miller J.M., Whetstone C.A., Bello L.J., Lawrence W.C., Determination of ability of a thymidine kinase-negative deletion mutant of bovine herpesvirus-1 to cause abortion in cattle, Am. J. Vet. Res. (1991) 52:1038-1043.
137. Miller J.M., Whetstone C.A., Van der Maaten M.J., Abortifacient property of bovine herpesvirus type 1 isolates that represent three subtypes determined by restriction endonuclease analysis of viral DNA, Am. J. Vet. Res. (1991) 52:458-461.
138. Misra V., Bratanich A.C., Carpenter D., O'Hare P., Protein and DNA elements involved in transactivation of the promoter of the bovine herpesvirus (BHV) 1 IE-1 transcription unit by the BHV alpha gene transinducing factor, J. Virol. (1994) 68:4898-4909.
139. Misra V., Walker S., Hayes S., O'Hare P., The bovine herpesvirus alpha gene trans-inducing factor activates transcription by mechanisms different from those of its herpes simplex virus type 1 counterpart VP16, J. Virol. (1995) 69:5209-5216.
140. Moffat J.F., Zerboni L., Kinchington P.R., Grose C., Kaneshima H., Arvin A.M., Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse, J. Virol. (1998) 72:965-974.
141. Molello J.A., Chow T.L., Owen N., Jensen R., Placental pathology. V. Placental lesions of cattle experimentally infected with infectious bovine rhinotracheitis virus, Am. J. Vet. Res. (1966) 27:907-915.
142. Muylkens B., Meurens F., Schynts F., de Fays K., Pourchet A., Thiry J., Vanderplasschen A., Antoine N., Thiry E., Biological characterization of bovine herpesvirus 1 recombinants possessing the vaccine glycoprotein E negative phenotype, Vet. Microbiol. (2006) 113:283-291.
143. Muylkens B., Meurens F., Schynts F., Farnir F., Pourchet A., Bardiau M., Gogev S., Thiry J., Cuisenaire A., Vanderplasschen A., Thiry E., Intraspecific bovine herpesvirus 1 recombinants carrying glycoprotein E deletion as a vaccine marker are virulent in cattle, J. Gen. Virol. (2006) 87:2149-2154.
144. Mweene A.S., Okazaki K., Kida H., Detection of viral genome in non-neural tissues of cattle experimentally infected with bovine herpesvirus 1, Jpn. J. Vet. Res. (1996) 44:165-174.
145. Narita M., Kimura K., Tanimura N., Arai S., Tsuboi T., Katsuda K., Immunohistochemical characterization of calf pneumonia produced by the combined endobronchial administration of bovine herpesvirus 1 and Pasteurella haemolytica, J. Comp. Pathol. (2000) 123:126-134.
146. Nataraj C., Eidmann S., Hariharan M.J., Sur J.H., Perry G.A., Srikumaran S., Bovine herpesvirus 1 downregulates the expression of bovine MHC class I molecules, Viral Immunol. (1997) 10:21-34.
147. Nauwynck H.J., Pensaert M.B., Abortion induced by cell-associated pseudorabies virus in vaccinated sows, Am. J. Vet. Res. (1992) 53:489-493.
148. Nauwynck H.J., Pensaert M.B., Effect of specific antibodies on the cell-associated spread of pseudorabies virus in monolayers of different cell types, Arch. Virol. (1995) 140:1137-1146.
149. Nichani A.K., Mena A., Kaushik R.S., Mutwiri G.K., Townsend H.G., Hecker R., Krieg A.M., Babiuk L.A., Griebel P.J., Stimulation of innate immune responses by CpG oligodeoxynucleotide in newborn lambs can reduce bovine herpesvirus-1 shedding, Oligonucleotides (2006) 16:58-67.
150. Nyaga P.N., McKercher D.G., Pathogenesis of bovine herpesvirus-1 (BHV-1) infections: interactions of the virus with peripheral bovine blood cellular components, Comp. Immunol. Microbiol. Infect. Dis. (1979) 2:587-602.
151. Okazaki K., Honda E., Kono Y., Expression of bovine herpesvirus 1 glycoprotein gIII by a recombinant baculovirus in insect cells, J. Gen. Virol. (1994) 75:901-904.
152. Okazaki K., Honda E., Kono Y., Heparin-binding domain of bovid herpesvirus 1 glycoprotein gIII, Arch. Virol. (1994) 134:413-419.
153. Oliveira S.C., Harms J.S., Rosinha G.M., Rodarte R.S., Rech E.L., Splitter G.A., Biolistic-mediated gene transfer using the bovine herpesvirus-1 glycoprotein D is an effective delivery system to induce neutralizing antibodies in its natural host, J. Immunol. Methods (2000) 245:109-118.
154. Owen N.V., Chow T.L., Molello J.A., Bovine fetal lesions experimentally produced by infectious bovine rhinotracheitis virus, Am. J. Vet. Res. (1964) 25:1617-1626.
155. Pastoret P.P., Aguilar-Setien A., Burtonboy G., Mager J., Jetteur P., Schoenaers F., Effect of repeated treatment with dexamethasone on the reexcretion pattern of infectious bovine rhinotracheitis virus and humoral immune response, Vet. Microbiol. (1979) 4:149-159.
156. Pauli G., Gregersen J.P., Storz J., Ludwig H., Biology and molecular biology of latent bovine herpes virus type 1 (BHV-1), in: Wittmann G., Gaskell R.M., Rziha H.J. (Eds.), Latent herpesvirus infections in veterinary medicine, Brussels-Luxembourg, Martinus Nijhoff Publishers, 1982, pp. 229-239.
157. Perez Filgueira D.M., Zamorano P.I., Dominguez M.G., Taboga O., Del Medico Zajac M.P., Puntel M., Romera S.A., Morris T.J., Borca M.V., Sadir A.M., Bovine herpes virus gD protein produced in plants using a recombinant tobacco mosaic virus (TMV) vector possesses authentic antigenicity, Vaccine (2003) 21:4201-4209.
158. Perez S., Inman M., Doster A., Jones C., Latency-related gene encoded by bovine herpesvirus 1 promotes virus growth and reactivation from latency in tonsils of infected calves, J. Clin. Microbiol. (2005) 43:393-401.
159. Perng G.C., Maguen B., Jin L., Mott K.R., Osorio N., Slanina S.M., Yukht A., Ghiasi H., Nesburn A.B., Inman M., Henderson G., Jones C., Wechsler S.L., A gene capable of blocking apoptosis can substitute for the herpes simplex virus type 1 latency-associated transcript gene and restore wildtype reactivation levels, J. Virol. (2002) 7:1224-1235.
160. Perrin B., Perrin M., Moussa A., Coudert M., Evaluation of a commercial gE blocking ELISA test for detection of antibodies to infectious bovine rhinotracheitis virus, Vet. Rec. (1996) 138:520.
161. Poffenberger K.L., Roizman B., A noninverting genome of a viable herpes simplex virus 1: presence of head-to-tail linkages in packaged genomes and requirements for circularization after infection, J. Virol. (1985) 53:587-595.
162. Rebordosa X., Pinol J., Perez-Pons J.A., Lloberas J., Naval J., Serra-Hartmann X., Espuna E., Querol E., Glycoprotein E of bovine herpesvirus type 1 is involved in virus transmission by direct cell-to-cell spread, Virus Res. (1996) 45:59-68.
163. Reddy P.S., Idamakanti N., Chen Y., Whale T., Babiuk L.A., Mehtali M., Tikoo S.K., Replication-defective bovine adenovirus type 3 as an expression vector, J. Virol. (1999) 73:9137-9144.
164. Reynolds A.E., Wills E.G., Roller R.J., Ryckman B.J., Baines J.D., Ultrastructural localization of the herpes simplex virus type 1 UL31, UL34, and US3 proteins suggests specific roles in primary envelopment and egress of nucleocapsids, J. Virol. (2002) 76:8939-8952.
165. Reynolds A.E., Liang L., Baines J.D., Conformational changes in the nuclear lamina induced by herpes simplex virus type 1 require genes U(L)31 and U(L)34, J. Virol. (2004) 78:5564-5575.
166. Rijsewijk F.A., Kaashoek M.J., Langeveld J.P., Meloen R., Judek J., Bienkowska-Szewczyk K., Maris-Veldhuis M.A., van Oirschot J.T., Epitopes on glycoprotein C of bovine herpesvirus-1 (BHV-1) that allow differentiation between BHV-1.1 and BHV-1.2 strains, J. Gen. Virol. (1999) 80:1477-1483.
167. Rock D., Lokensgard J., Lewis T., Kutish G., Characterization of dexamethasone-induced reactivation of latent bovine herpesvirus 1, J. Virol. (1992) 66:2484-2490.
168. Roels S., Charlier G., Letellier C., Meyer G., Schynts F., Kerkhofs P., Thiry E., Vanopdenbosch E., Natural case of bovine herpesvirus 1 meningoencephalitis in an adult cow, Vet. Rec. (2000) 146:586-588.
169. Roizman B., Knipe M.D., Herpes simplex virus and their replication, Lippincott Williams and Wilkins, Philadelphia, 2000.
170. Saira K., Jones C., BHV-1 gene encoding infected cell protein (BICP0) inhibits antiviral signaling by inducing IRF3 degradation, in proceedings of the 31st International Herpesvirus Workshop, Seattle, 2006, abstract 8.39.
171. Saydam O., Abril C., Vogt B., Ackermann M., Schwyzer M., Transactivator protein BICP0 of bovine herpesvirus 1 (BHV-1) is blocked by prostaglandin D2 (PGD2), which points to a mechanism for PGD2-mediated inhibition of BHV-1 replication, J. Virol. (2004) 78:3805-3810.
172. Saydam O., Steiner F., Vogt B., Schwyzer M., Host cell targets of immediate-early protein BICP22 of bovine herpesvirus 1, Vet. Microbiol. (2006) 113:185-192.
173. Schang L.M., Hossain A., Jones C., The latency-related gene of bovine herpesvirus 1 encodes a product which inhibits cell cycle progression, J. Virol. (1996) 70:3807-3814.
174. Schroder C., Linde G., Fehler F., Keil G.M., From essential to beneficial: glycoprotein D loses importance for replication of bovine herpesvirus 1 in cell culture, J. Virol. (1997) 71:25-33.
175. Schroder C., Keil G.M., Bovine herpesvirus 1 requires glycoprotein H for infectivity and direct spreading and glycoproteins gH(W450) and gB for glycoprotein D-independent cell-to-cell spread, J. Gen. Virol. (1999) 80:57-61.
176. Schroeder R.J., Moys M.D., An acute respiratory infection of dairy cattle, J. Am. Vet. Med. Assoc. (1954) 125:471-472.
177. Schumacher D., Tischer B.K., Trapp S., Osterrieder N., The protein encoded by the US3 orthologue of Marek's disease virus is required for efficient de-envelopment of perinuclear virions and involved in actin stress fiber breakdown, J. Virol. (2005) 79:3987-3997.
178. Schwyzer M., Ackermann M., Molecular virology of ruminant herpesviruses, Vet. Microbiol. (1996) 53:17-29.
179. Schwyzer M., Styger D., Vogt B., Lowery D.E., Simard C., LaBoissiere S., Misra V., Vlcek C., Paces V., Gene contents in a 31-kb segment at the left genome end of bovine herpesvirus-1, Vet. Microbiol. (1996) 53:67-77.
180. Schynts F., Meurens F., Muylkens B., Epstein A., McVoy M., Thiry E., Réplication, clivage-encapsidation et recombinaison de l'ADN des herpèsvirus, Virologie (2002) 6:343-352.
181. Schynts F., McVoy M.A., Meurens F., Detry B., Epstein A.L., Thiry E., The structures of bovine herpesvirus 1 virion and concatemeric DNA: implications for cleavage and packaging of herpesvirus genomes, Virology (2003) 314:326-335.
182. Schynts F., Meurens F., Detry B., Vanderplasschen A., Thiry E., Rise and survival of bovine herpesvirus 1 recombinants after primary infection and reactivation from latency, J. Virol. (2003) 77:12535-12542.
183. Severini A., Morgan A.R., Tovell D.R., Tyrrell D.L., Study of the structure of replicative intermediates of HSV-1 DNA by pulsed-field gel electrophoresis, Virology (1994) 200:428-435.
184. Severini A., Scraba D.G., Tyrrell D.L., Branched structures in the intracellular DNA of herpes simplex virus type 1, J. Virol. (1996) 70:3169-3175.
185. Sheffy B.E., Davies D.H., Reactivation of a bovine herpesvirus after corticosteroid treatment, Proc. Soc. Exp. Biol. Med. (1972) 140:974-976.
186. Simard C., Langlois I., Styger D., Vogt B., Vlcek C., Chalifour A., Trudel M., Schwyzer M., Sequence analysis of the UL39, UL38, and UL37 homologues of bovine herpesvirus 1 and expression studies of UL40 and UL39, the subunits of ribonucleotide reductase, Virology (1995) 212:734-740.
187. Smith G.A., Young P.L., Reed K.C., Emergence of a new bovine herpesvirus 1 strain in Australian feedlots, Arch. Virol. (1995) 140:599-603.
188. Smith V.W., Coakley W., Maker D., Transmission of a genital isolate of bovine herpesvirus 1 to calves by the respiratory route, Aust. Vet. J. (1980) 56:302-304.
189. Solis-Calderon J.J., Segura-Correa V.M., Segura-Correa J.C., Alvarado-Islas A., Seroprevalence of and risk factors for infectious bovine rhinotracheitis in beef cattle herds of Yucatan, Mexico, Prev. Vet. Med. (2003) 57:199-208.
190. Spilki F.R., Esteves P.A., de Lima M., Franco A.C., Chiminazzo C., Flores E.F., Weiblen R., Driemeier D., Roehe P.M., Comparative pathogenicity of bovine herpesvirus 1 (BHV-1) subtypes 1 (BHV-1.1) and 2a (BHV-1.2a), Pesquisa Veterinaria Brasileira (2004) 24:43-49.
191. Spilki F.R., Esteves P.A., da Silva A.D., Franco A.C., Rijsewijk F.A., Roehe P.M., A monoclonal antibody-based ELISA allows discrimination between responses induced by bovine herpesvirus subtypes 1 (BoHV-1.1) and 2 (BoHV-1.2), J. Virol. Methods (2005) 129:191-193.
192. Spurzem J.R., Raz M., Ito H., Kelling C.L., Stine L.C., Romberger D.J., Rennard S.I., Bovine herpesvirus-1 infection reduces bronchial epithelial cell migration to extracellular matrix proteins, Am. J. Physiol. (1995) 268:L214-220.
193. Thiry E., Saliki J., Schwers A., Pastoret P.P., Parturition as a stimulus of IBR virus reactivation, Vet. Rec. (1985) 116:599-600.
194. Thiry E., Saliki J., Bublot M., Pastoret P.P., Reactivation of infectious bovine rhinotracheitis virus by transport, Comp. Immunol. Microbiol. Infect. Dis. (1987) 10:59-63.
195. Thiry E., Meurens F., Muylkens B., McVoy M., Gogev S., Thiry J., Vanderplasschen A., Epstein A., Keil G., Schynts F., Recombination in alphaherpesviruses, Rev. Med. Virol. (2005) 15:89-103.
196. Thiry E., Muylkens B., Meurens F., Gogev S., Thiry J., Vanderplasschen A., Schynts F., Recombination in the alphaherpesvirus bovine herpesvirus 1, Vet. Microbiol. (2006) 113:171-177.
197. Thiry J., Keuser V., Muylkens B., Meurens F., Gogev S., Vanderplasschen A., Thiry E., Ruminant alphaherpesviruses related to bovine herpesvirus 1, Vet. Res. (2006) 37:169-190.
198. Tikoo S.K., Campos M., Babiuk L.A., Bovine herpesvirus 1 (BHV-1): biology, pathogenesis, and control, Adv. Virus Res. (1995) 45:191-223.
199. Toussaint J.F., Coen L., Letellier C., Dispas M., Gillet L., Vanderplasschen A., Kerkhofs P., Genetic immunisation of cattle against bovine herpesvirus 1: glycoprotein gD confers higher protection than glycoprotein gC or tegument protein VP8, Vet. Res. (2005) 36:529-544.
200. Toussaint J.F., Letellier C., Paquet D., Dispas M., Kerkhofs P., Prime-boost strategies combining DNA and inactivated vaccines confer high immunity and protection in cattle against bovine herpesvirus-1, Vaccine (2005) 23:5073-5081.
201. Trapp S., Osterrieder N., Keil G.M., Beer M., Mutagenesis of a bovine herpesvirus type 1 genome cloned as an infectious bacterial artificial chromosome: analysis of glycoprotein E and G double deletion mutants, J. Gen. Virol. (2003) 84:301-306.
202. Van der Meulen K., Caij B., Pensaert M., Nauwynck H., Absence of viral envelope proteins in equine herpesvirus 1-infected blood mononuclear cells during cell-associated viremia, Vet. Microbiol. (2006) 113:265-273.
203. Van Drunen Littel-van den Hurk S., Tikoo S.K., Liang X., Babiuk L.A., Bovine herpesvirus-1 vaccines, Immunol. Cell Biol. (1993) 71:405-420.
204. Van Drunen Littel-van den Hurk S., Van Donkersgoed J., Kowalski J., van den Hurk J.V., Harland R., Babiuk L.A., Zamb T.J., A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle, Vaccine (1994) 12:1295-1302.
205. Van Drunen Littel-van den Hurk S., Garzon S., van den Hurk J.V., Babiuk L.A., Tijssen P., The role of the major tegument protein VP8 of bovine herpesvirus-1 in infection and immunity, Virology (1995) 206:413-425.
206. Van Drunen Littel-van den Hurk S., Rationale and perspectives on the success of vaccination against bovine herpesvirus-1, Vet. Microbiol. (2006) 113:275-282.
207. Van Engelenburg F.A., Kaashoek M.J., van Oirschot J.T., Rijsewijk F.A., A glycoprotein E deletion mutant of bovine herpesvirus 1 infects the same limited number of tissues in calves as wild-type virus, but for a shorter period, J. Gen. Virol. (1995) 76:2387-2392.
208. Van Schaik G., Shoukri M., Martin S.W., Schukken Y.H., Nielen M., Hage J.J., Dijkhuizen A.A., Modeling the effect of an outbreak of bovine herpesvirus type 1 on herd-level milk production of Dutch dairy farms, J. Dairy Sci. (1999) 82:944-952.
209. Van Schaik G., Risk and economics of disease introduction to dairy farms, Tijdschr. Diergeneeskd. (2001) 126:414-418 (in Dutch).
210. Van Schaik G., Schukken Y.H., Nielen M., Dijkhuizen A.A., Benedictus G., Risk factors for introduction of BHV1 into BHV1-free Dutch dairy farms: a case-control study, Vet. Q. (2001) 23:71-76.
211. Van Schaik G., Schukken Y.H., Nielen M., Dijkhuizen A.A., Barkema H.W., Benedictus G., Probability of and risk factors for introduction of infectious diseases into Dutch SPF dairy farms: a cohort study, Prev. Vet. Med. (2002) 54:279-289.
212. Van Oirschot J.T., Kaashoek M.J., Maris Veldhuis M.A., Weerdmeester K., Rijsewijk F.A.M., An enzyme-linked immunosorbent assay to detect antibodies against glycoprotein gE of bovine herpesvirus 1 allows differentiation between infected and vaccinated cattle, J. Virol. Methods (1997) 67:23-34.
213. Vlcek C., Benes V., Lu Z., Kutish G.F., Paces V., Rock D., Letchworth G.J., Schwyzer M., Nucleotide sequence analysis of a 30-kb region of the bovine herpesvirus 1 genome which exhibits a colinear gene arrangement with the UL21 to UL4 genes of herpes simplex virus, Virology (1995) 210:100-108.
214. Vonk Noordegraaf A., Labrovic A., Frankena K., Pfeiffer D.U., Nielen M., Simulated hazards of loosing infection-free status in a Dutch BHV1 model, Prev. Vet. Med. (2004) 62:51-58.
215. Warren L.M., Babiuk L.A., Campos M., Effects of BHV-1 on PMN adhesion to bovine lung endothelial cells, Vet. Immunol. Immunopathol. (1996) 55:73-82.
216. Whetstone C.A., Miller J.M., Two different strains of an alphaherpesvirus can establish latency in the same tissue of the host animal: evidence from bovine herpesvirus 1, Arch. Virol. (1989) 107:27-34.
217. Whetstone C.A., Miller J.M., Seal B.S., Bello L.J., Lawrence W.C., Latency and reactivation of a thymidine kinase-negative bovine herpesvirus 1 deletion mutant, Arch. Virol. (1992) 122:207-214.
218. Wild P., Engels M., Senn C., Tobler K., Ziegler U., Schraner E.M., Loepfe E., Ackermann M., Mueller M., Walther P., Impairment of nuclear pores in bovine herpesvirus 1-infected MDBK cells, J. Virol. (2005) 79:1071-1083.
219. Winkler M.T., Doster A., Jones C., Bovine herpesvirus 1 can infect CD4(+) T lymphocytes and induce programmed cell death during acute infection of cattle, J. Virol. (1999) 73:8657-8668.
220. Winkler M.T., Doster A., Jones C., Persistence and reactivation of bovine herpesvirus 1 in the tonsils of latently infected calves, J. Virol. (2000) 74:5337-5346.
221. Wirth U.V., Gunkel K., Engels M., Schwyzer M., Spatial and temporal distribution of bovine herpesvirus 1 transcripts, J. Virol. (1989) 63:4882-4889.
222. Wirth U.V., Vogt B., Schwyzer M., The three major immediate-early transcripts of bovine herpesvirus 1 arise from two divergent and spliced transcription units, J. Virol. (1991) 65:195-205.
223. Wirth U.V., Fraefel C., Vogt B., Vlcek C., Paces V., Schwyzer M., Immediate-early RNA 2.9 and early RNA 2.6 of bovine herpesvirus 1 are 3′ coterminal and encode a putative zinc finger transactivator protein, J. Virol. (1992) 66:2763-2772.
224. Wu S.X., Zhu X.P., Letchworth G.J., Bovine herpesvirus 1 glycoprotein Mforms a disulfide-linked heterodimer with the U(L)49.5 protein, J. Virol. (1998) 72:3029-3036.
225. Wyler R., Engels M., Schwyzer M., Infectious bovine rhinotracheitis/ vuvlvovaginitis, Kluwer academic publishers, Boston, Dordrecht, London, 1989.
226. Zakhartchouk A.N., Pyne C., Mutwiri G.K., Papp Z., Baca-Estrada M.E., Griebel P., Babiuk L.A., Tikoo S.K., Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1, J. Gen. Virol. (1999) 80:1263-1269.
227. Zheng C., Brownlie R., Babiuk L.A., van Drunen Littel-van den Hurk S., Characterization of nuclear localization and export signals of the major tegument protein VP8 of bovine herpesvirus-1, Virology (2004) 324:327-339.